R
Raymond R. Townsend
Researcher at University of Pennsylvania
Publications - 706
Citations - 47086
Raymond R. Townsend is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Blood pressure & Kidney disease. The author has an hindex of 84, co-authored 673 publications receiving 39096 citations. Previous affiliations of Raymond R. Townsend include University of Texas Medical Branch & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Interventional management in hypertension: where do we stand?
TL;DR: This finding seems to be more of a speed-bump than a ‘road closed’ sign for renal denervation, a prompt to reconsider the adequacy of denervation techniques and an encouragement to continue the search for robust predictors of clinical response.
Journal ArticleDOI
Physical Activity Following Positive Airway Pressure Treatment in Adults With and Without Obesity and With Moderate-Severe Obstructive Sleep Apnea.
Yuan Feng,David Maislin,Brendan T. Keenan,Thorarinn Gislason,Erna S. Arnardottir,Bryndis Benediktsdottir,Julio A. Chirinos,Raymond R. Townsend,Bethany Staley,Francis M Pack,Andrea Sifferman,Allan I. Pack,Samuel T. Kuna,Samuel T. Kuna +13 more
TL;DR: PA increased significantly in participants without obesity, with OSA, and who were adherent to PAP treatment, indicating that treatment of OSA is unlikely to be associated with a change in PA in adults with obesity and OSA.
Journal ArticleDOI
Is Ambulatory Blood Pressure Monitoring Finally Catching On
TL;DR: Nighttime BP measured by ABPM is superior to office BP measurement in predicting CV events, and this is demonstrated in a report from the International Database of Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes (IDACO).
Journal ArticleDOI
Is BP lowering during acute intracerebral hemorrhage safe
TL;DR: It appears to be safe to lower the systolic BP within about 6 hours of an ICH, and there may be a small benefit to doing so in terms of symptoms and disabilities following stroke, bearing in mind that many of the participants were Chinese and that the main drug used was urapidil, which is not available in the United States.
Journal ArticleDOI
Treatment Expectations in Hypertension
TL;DR: Automated systems employing clinical decision support at the point of care and internet-based patient support strategies offer the hope that comprehensive, individualized disease management for hypertension can be affordable as well as effective.